Brian John Smith
8Patents
4h-index
31Co-inventors
53Inventor score
Filing activity: Dec 17, 2009 → Jan 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8114893B2 | Compounds and methods of use | Chemistry; Metallurgy | 42 | Active |
| US8518970B2 | Compounds and methods of use | Chemistry; Metallurgy | 28 | Active |
| US8232273B2 | Heterocyclic compounds and methods of use | Chemistry; Metallurgy | 26 | Active |
| US9067928B2 | Compounds and methods of use | Chemistry; Metallurgy | 5 | Active |
| US11248034B2 | Insulin analogs | Chemistry; Metallurgy | 1 | Active |
| US8666718B2 | Structure of the C-terminal region of the insulin receptor α-chain and of the insulin-like growth factor receptor α-chain | Physics | 0 | Active |
| US10246496B2 | Potassium channel blockers and use thereof in the treatment of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US12410228B2 | Insulin analogs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.